Abstract
Systemic administration of lysine to mice injected with indium-111-labelled Fab fragment of a monoclonal antibody has been shown to reduce renal uptake/retention of the radiometal. This treatment should be applicable to clinical immunoscintigraphy and radioimmunotherapy with radiometal-labelled antibody fragments.
References
Hammond PJ, Wade AF, Gwilliam ME, Peters AM, Myers MJ, Gilbey SG, Bloom SR, Calam J. Amino acid infusion blocks renal tubule uptake of indium-labelled somatostatin analoque. Br J Cancer 1993;67: 1437–1439.
Buist MR, Kenemans P, Hollander W, Vermorken JB, Molthoff CJM, Burger CW, Helmerhorst TJM, Baak JPA, Roos JC. Kinetics and tissue distribution of the radiolabeled chimeric monoclonal antibody MOv18 IgG and F(ab′)2 fragments in ovarian carcinoma patients. Cancer Res 1993;15 5413–5418.
Smith A, Alberto R, Blaeuenstein P, Novak-Hofer I, Maecke HR, Schubiger PA. Preclinical evaluation of 67Cu-labeled intact and fragmented anti-colon carcinoma monoclonal antibody MAb35. Cancer Res 1993;53: 5727–5733.
Schott ME, Milenic DE, Yokota T, Whitlow M, Wood JF, Fordyce WA, Cheng RC, Schlom J. Differential patterns of iodinated versus radiometal chelated anticarcinoma single-chain Fv molecules. Cancer Res 1992;52: 6413–6417.
Duncan JR, Welch MJ. Intracellular metabolism of indium-111-DTPA labeled receptor targeted proteins. J Nucl Med 1993;34: 1728–1738.
Mogenson CE, Solling K. Studies on renal tubular protein reabsorption: partial and near complete inhibition by certain amino acids. Scand J Clin Lab Invest 1977;37 477–486.
Andrew SM, Perkins AC, Pimm MV, Baldwin RW. A comparison of iodine and indium labelled anti-CEA intact antibody, F(ab′)2 and Fab fragments by imaging tumour xenografts. Eur J Nucl Med 1988;13: 598–604.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Pimm, M.V., Gribben, S.J. Prevention of renal tubule re-absorption of radiometal (indium-111) labelled Fab fragment of a monoclonal antibody in mice by systemic administration of lysine. Eur J Nucl Med 21, 663–665 (1994). https://doi.org/10.1007/BF00285590
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF00285590